NICE approves third monoclonal antibody treatment for migraine

By Lisa Lytle, 10 March 2021

Erenumab (Aimovig) is the third member of the CGRP...

Pregabalin linked to severe respiratory depression in absence of opioids

By Lisa Lytle, 24 February 2021

The MHRA advises prescribers to consider adjustment...

Novel MS drug gains NICE approval

By Lisa Lytle, 17 June 2019

New NICE guidance recommends ocrelizumab (Ocrevus)...